Equities Analysts Issue Forecasts for CRSP Q2 Earnings
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Stock analysts at William Blair reduced their Q2 2025 EPS estimates for CRISPR Therapeutics in a research note issued on Wednesday, May 7th. William Blair analyst S. Corwin now forecasts that the company will earn ($1.10) per share for the quarter, down from their prior forecast of […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Stock analysts at William Blair reduced their Q2 2025 EPS estimates for CRISPR Therapeutics in a research note issued on Wednesday, May 7th. William Blair analyst S. Corwin now forecasts that the company will earn ($1.10) per share for the quarter, down from their prior forecast of […]
